IntrinsicIntrinsic
← Scroll for more →

Financial Statements — MNOV

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Cash & Equivalents25.4227.3330.8132.5634.2636.5740.3642.2844.3447.1451.0051.5152.8818.5152.5165.2367.7071.4375.0377.79
Short-term Investments------------------------39.9839.98------------
Accounts Receivable0.000.25--0.000.13------------1.00----------------
Total Current Assets25.9228.1530.9932.9235.1237.6841.0743.2745.5147.8651.1753.0053.5258.9953.1565.9668.8372.0176.1678.91
Property, Plant & Equipment0.010.010.010.010.020.020.030.030.040.040.050.050.050.050.050.050.050.060.060.07
Goodwill9.609.609.609.609.609.609.609.609.609.609.609.609.609.609.609.609.609.609.609.60
Total Non-current Assets*14.5114.5614.6114.6614.7014.7514.8014.8514.9015.0315.1015.1415.2015.1725.2415.2815.3415.4015.4614.77
Total Assets40.4342.7045.6047.5849.8252.4355.8858.1260.4062.8966.2768.1468.7274.1578.3981.2484.1887.4191.6293.68
Accounts Payable0.950.850.620.750.570.721.100.710.670.801.000.740.550.420.550.640.670.400.640.61
Total Current Liabilities2.963.103.803.342.652.132.962.602.492.513.282.802.823.194.533.842.982.834.202.47
Total Non-current Liabilities*0.200.200.220.280.320.370.410.460.500.550.610.670.720.730.760.790.830.900.941.98
Total Liabilities3.163.304.023.612.972.503.373.053.003.063.893.473.543.915.294.633.813.735.144.45
Retained Earnings(443.65)(441.34)(438.75)(435.95)(432.90)(429.62)(426.75)(423.94)(421.08)(418.46)(415.70)(413.64)(412.92)(407.13)(404.13)(400.48)(396.45)(393.06)(390.98)(387.40)
Total Stockholder Equity37.2739.4141.5943.9646.8649.9352.5055.0757.4159.8362.3864.6765.1870.2473.1176.6180.3683.6886.4889.23
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Total Revenue0.460.190.150.120.13----------0.001.00----4.044.00--0.000.040.00
Research & Development0.901.201.501.502.001.701.801.801.501.701.600.701.601.802.402.502.001.802.002.30
Selling, General & Admin1.831.591.551.811.441.361.281.451.401.350.841.351.561.221.441.521.300.331.551.78
Total Operating Expenses3.003.023.243.503.743.203.183.313.053.142.492.153.303.233.904.093.412.103.644.31
Operating Income(2.54)(2.84)(3.09)(3.38)(3.61)(3.20)(3.18)(3.31)(3.05)(3.14)(2.49)(1.15)(3.30)(3.23)(3.90)(4.09)(3.41)(2.10)(3.60)(4.31)
Net Income(2.31)(2.59)(2.80)(3.05)(3.28)(2.86)(2.81)(2.85)(2.63)(2.75)(2.06)(0.72)(2.87)(3.00)(3.65)(4.03)(3.39)(2.08)(3.58)(4.28)
Basic EPS(0.05)(0.05)(0.05)(0.06)(0.07)(0.06)(0.06)(0.06)(0.05)(0.06)(0.04)(0.01)(0.06)(0.06)(0.07)(0.08)--------
Diluted EPS(0.05)(0.05)(0.05)(0.06)(0.07)(0.06)(0.06)(0.06)(0.05)(0.06)(0.04)(0.01)(0.06)(0.06)(0.07)(0.08)--------
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Operating Cash Flow(1.92)(3.47)(2.02)(1.70)(2.31)(3.78)(1.93)(2.03)(2.81)(3.87)(0.50)(6.93)(3.18)(4.01)(2.72)(2.46)(3.73)(3.64)(3.02)1.13
Capital Expenditures0.000.010.000.00-----0.000.000.00---0.000.020.02--------0.000.000.03
Free Cash Flow*(1.92)(3.48)(2.02)(1.71)----(1.93)(2.03)(2.81)--(0.50)(6.95)(3.20)--------(3.64)(3.02)1.10
Investing Cash Flow0.00(0.01)0.00-0.00----0.000.00-0.00--0.0039.9139.93(30.01)(10.00)----0.00-0.00(0.03)
Financing Cash Flow--------------------------0.000.000.01--0.040.250.39
← Scroll for more columns →

* Derived from reported values